COPENHAGEN, Denmark, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results ...

Voyager Therapeutics said it will assess alternate payloads related to its gene therapeutic program related to a form of amyotrophic lateral sclerosis, also known as Lou Gehrig's disease.

A biotechnology company in Research Triangle Park has taken a major step to develop a new option for patients in need of a ...

SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the 'Company') declared today that it is ready to fight the bird f ...

The innovative drug candidate represents a novel approach to antithrombotic treatment without an increased risk of bleeding. CS014 is a new chemical entity with a multi-modal mechanism of action ...

Operator Good afternoon, everyone, and welcome to Gilead's fourth quarter and full year 2024 earnings conference call. My ...

A nasal COVID-19 vaccine, developed using technology from Washington University in St. Louis, is set to begin a Phase 1 clinical trial in the U.S. following FDA approval of an investigational new drug ...

We are giving you the First Alert to one more warm day before we see much cooler air move in as well as rounds of rain through next week. Resolution 246 will allow the sale of about 63.6 acres of ...

“Recently we’ve seen concerning actions, including hostile social media posts targeting city officials and staff,” Brandy Amidon, mayor of Travelers Rest, said. The arguments for Planned ...

Researchers, led by the University of Melbourne's Professor Laura Mackay, a Laboratory Head and Immunology Theme Leader at ...

A team of researchers from the Keck School of Medicine of USC has unlocked the details of a cellular pathway that triggers ...